These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 9022008)

  • 1. CD21 augments antigen presentation in immune individuals.
    Boackle SA; Holers VM; Karp DR
    Eur J Immunol; 1997 Jan; 27(1):122-9. PubMed ID: 9022008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement opsonization is required for presentation of immune complexes by resting peripheral blood B cells.
    Boackle SA; Morris MA; Holers VM; Karp DR
    J Immunol; 1998 Dec; 161(12):6537-43. PubMed ID: 9862679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-linking CD21/CD35 or CD19 increases both B7-1 and B7-2 expression on murine splenic B cells.
    Kozono Y; Abe R; Kozono H; Kelly RG; Azuma T; Holers VM
    J Immunol; 1998 Feb; 160(4):1565-72. PubMed ID: 9469411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD23/CD21 interaction is required for presentation of soluble protein antigen by lymphoblastoid B cell lines to specific CD4+ T cell clones.
    Grosjean I; Lachaux A; Bella C; Aubry JP; Bonnefoy JY; Kaiserlian D
    Eur J Immunol; 1994 Dec; 24(12):2982-6. PubMed ID: 7805725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for an important interaction between a complement-derived CD21 ligand on follicular dendritic cells and CD21 on B cells in the initiation of IgG responses.
    Qin D; Wu J; Carroll MC; Burton GF; Szakal AK; Tew JG
    J Immunol; 1998 Nov; 161(9):4549-54. PubMed ID: 9794381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of the complement C3 protein in the control of the specific immune response].
    Villiers CL; Villiers MB; Marche PN
    Ann Biol Clin (Paris); 1999; 57(2):127-35. PubMed ID: 10210739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement receptors CD21 and CD35 in humoral immunity.
    Roozendaal R; Carroll MC
    Immunol Rev; 2007 Oct; 219():157-66. PubMed ID: 17850488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ligation of the functional domain of complement receptor type 2 (CR2, CD21) is relevant for complex formation in T cell lines.
    Prodinger WM; Larcher C; Schwendinger M; Dierich MP
    J Immunol; 1996 Apr; 156(7):2580-4. PubMed ID: 8786322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD21/CD35 in B cell activation.
    Carroll MC
    Semin Immunol; 1998 Aug; 10(4):279-86. PubMed ID: 9695184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Covalent binding of C3b to monoclonal antibodies selectively up-regulates heavy chain epitope recognition by T cells.
    Santoro L; Drouet C; Reboul A; Mach JP; Colomb MG
    Eur J Immunol; 1994 Jul; 24(7):1620-6. PubMed ID: 8026522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of signaling via the B cell antigen receptor by CD21, the receptor for C3dg and EBV.
    Luxembourg AT; Cooper NR
    J Immunol; 1994 Nov; 153(10):4448-57. PubMed ID: 7525704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement's participation in acquired immunity.
    Nielsen CH; Leslie RG
    J Leukoc Biol; 2002 Aug; 72(2):249-61. PubMed ID: 12149415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B cell activation leads to shedding of complement receptor type II (CR2/CD21).
    Masilamani M; Kassahn D; Mikkat S; Glocker MO; Illges H
    Eur J Immunol; 2003 Sep; 33(9):2391-7. PubMed ID: 12938215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigen-bound C3b and C4b enhance antigen-presenting cell function in activation of human T-cell clones.
    Arvieux J; Yssel H; Colomb MG
    Immunology; 1988 Oct; 65(2):229-35. PubMed ID: 2973431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human lymphocytes shed a soluble form of CD21 (the C3dg/Epstein-Barr virus receptor, CR2) that binds iC3b and CD23.
    Frémeaux-Bacchi V; Bernard I; Maillet F; Mani JC; Fontaine M; Bonnefoy JY; Kazatchkine MD; Fischer E
    Eur J Immunol; 1996 Jul; 26(7):1497-503. PubMed ID: 8766552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Capacity of antigen uptake by B cells, fibroblasts or macrophages determines efficiency of presentation of a soluble self antigen (C5) to T lymphocytes.
    Stockinger B
    Eur J Immunol; 1992 May; 22(5):1271-8. PubMed ID: 1577067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of B lymphocyte activation by complement C3 and the B cell coreceptor complex.
    Rickert RC
    Curr Opin Immunol; 2005 Jun; 17(3):237-43. PubMed ID: 15886112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement receptor 2, natural antibodies and innate immunity: Inter-relationships in B cell selection and activation.
    Holers VM; Kulik L
    Mol Immunol; 2007 Jan; 44(1-3):64-72. PubMed ID: 16876864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural antibody and complement-mediated antigen processing and presentation by B lymphocytes.
    Thornton BP; Vĕtvicka V; Ross GD
    J Immunol; 1994 Feb; 152(4):1727-37. PubMed ID: 8120381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of Epstein-Barr virus nuclear antigen-2 (EBNA2) induces CD21/CR2 on B and T cell lines and shedding of soluble CD21.
    Larcher C; Kempkes B; Kremmer E; Prodinger WM; Pawlita M; Bornkamm GW; Dierich MP
    Eur J Immunol; 1995 Jun; 25(6):1713-9. PubMed ID: 7614999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.